M1巨噬细胞外泌体经miR-212-5p靶向SIRT2抑制Akt/GSK-3β/β-catenin通路损害小鼠β细胞胰岛素分泌
该研究在高脂饮食小鼠中分析胰岛巨噬细胞表型,并提取M1型骨髓来源巨噬细胞及高脂饮食小鼠胰岛巨噬细胞的外泌体,在体内外评估其对β细胞功能的影响。结果显示M1外泌体经miR-212-5p靶向SIRT2并调控Akt/GSK-3β/β-catenin通路,损害β细胞胰岛素分泌。
要点
- 肥胖小鼠胰岛中M1极化巨噬细胞增多,其外泌体可损害β细胞胰岛素分泌。
- M1外泌体将miR-212-5p转移至β细胞,靶向SIRT2并调控Akt/GSK-3β/β-catenin通路。
- 阻断miR-212-5p可显著改善M1外泌体介导的β细胞胰岛素分泌损伤。
核心结论
- M1巨噬细胞来源外泌体通过miR-212-5p靶向SIRT2并调控Akt/GSK-3β/β-catenin通路,损害小鼠β细胞胰岛素分泌。
- 该研究揭示了巨噬细胞与β细胞间外泌体介导的通讯机制,并提示其治疗探索价值。
研究设计与样本
- 研究分析高脂饮食喂养C57BL/6J小鼠胰岛驻留巨噬细胞的表型。
- 从培养的骨髓来源巨噬细胞(BMDM)及高脂饮食小鼠分离的胰岛驻留巨噬细胞中收集外泌体(HFD-Exos)。
- 在体外和体内评估炎症M1表型BMDM分泌的外泌体(M1-Exos)及HFD-Exos对β细胞功能的作用。
- 采用miRNA微阵列和qPCR检测β细胞中M1-Exos来源miR-212-5p水平,并通过过表达或抑制miR-212-5p确定其分子和功能影响。
主要发现
- 肥胖小鼠胰岛中M1极化巨噬细胞富集。
- M1巨噬细胞及高脂饮食小鼠胰岛驻留巨噬细胞以依赖外泌体的方式损害β细胞胰岛素分泌。
- miR-212-5p在M1-Exos和HFD-Exos中显著上调。
- 增强miR-212-5p表达损害β细胞胰岛素分泌;阻断miR-212-5p可显著改善M1-Exos介导的β细胞胰岛素分泌损伤。
- M1-Exos介导miR-212-5p的细胞间转移,靶向SIRT2基因并调控受体β细胞中Akt/GSK-3β/β-catenin通路以限制胰岛素分泌。
临床怎么用
- 提示巨噬细胞来源外泌体及其miR-212-5p可能作为肥胖和2型糖尿病β细胞功能障碍的干预靶点。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Macrophage levels are elevated in pancreatic islets, and the resulting inflammatory response is a major contributor to beta cell failure during obesity and type 2 diabetes mellitus. Previous studies by us and others have reported that exosomes released by macrophages play important roles in mediating cell-to-cell communication, and represent a class of inflammatory factors involved in the inflammatory process associated with type 2 diabetes mellitus. However, to date, no reports have demonstrated the effect of macrophage-derived exosomes on beta cells, and little is known regarding their underlying mechanisms in beta cell injury. Thus, we aimed to study the impact of macrophage-derived exosomes on islet beta cell injury in vitro and in vivo. METHODS: The phenotypic profiles of islet-resident macrophages were analysed in C57BL/6J mice fed a high-fat diet (HFD). Exosomes were collected from the medium of cultured bone marrow-derived macrophages (BMDMs) and from isolated islet-resident macrophages of HFD-fed mice (HFD-Exos). The role of exosomes secreted by inflammatory M1 phenotype BMDMs (M1-Exos) and HFD-Exos on beta cell function was assessed. An miRNA microarray and quantitative real-time PCR (qPCR) were conducted to test the level of M1-Exos-derived miR-212-5p in beta cells. Then, miR-212-5p was overexpressed or inhibited in M1-Exos or beta cells to determine its molecular and functional impact. RESULTS: M1-polarised macrophages were enriched in the islets of obese mice. M1 macrophages and islet-resident macrophages of HFD-fed mice impaired beta cell insulin secretion in an exosome-dependent manner. miR-212-5p was notably upregulated in M1-Exos and HFD-Exos. Enhancing the expression of miR-212-5p impaired beta cell insulin secretion. Blocking miR-212-5p elicited a significant improvement in M1-Exos-mediated beta cell insulin secretion during injury. Mechanistically, M1-Exos mediated an intercellular transfer of the miR-212-5p, targeting the sirtuin 2 gene and regulating the Akt/GSK-3β/β-catenin pathway in recipient beta cells to restrict insulin secretion. CONCLUSIONS/INTERPRETATION: A novel exosome-modulated mechanism was delineated for macrophage-beta cell crosstalk that drove beta cell dysfunction and should be explored for its therapeutic utility.
引用
- Qian B, Yang Y, Tang N, et al. M1 macrophage-derived exosomes impair beta cell insulin secretion via miR-212-5p by targeting SIRT2 and inhibiting Akt/GSK-3β/β-catenin pathway in mice. Diabetologia. 2021. PMID: 34117507. doi:10.1007/s00125-021-05489-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。